Medpace logo
Medpace
MEDP | NASDAQ
Chart Builder DCF Calculator
$648.20
-$5.74 (-0.88%)
At close: Nov 16, 2026, 4:00 PM ET
$648.20
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Medpace Company Profile

Company profile explained

Company Profile

Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.

Key Executives

Name Position
August James Troendle CEO, President & Chairman
Kevin Brady Chief Financial Officer & Treasurer
Brad W. Hansman Executive Vice President of Operations
Gina Leisring Senior Vice President of Clinical Monitoring
John T. Wynne Chief Business Officer
Lauren Morris Associate Director of Investors Relations
Reinilde Heyrman Chief Medical Officer of Medical Department
Stephen Ewald Chief Compliance Officer, General Counsel & Corporate Secretary
Todd Meyers Vice President of Business Development & Marketing
Weimin Gai Senior Vice President of Biometrics

Latest SEC Filings

Date Type Title
Oct 28, 2026 4 Filing
Oct 23, 2026 4 Filing
Oct 22, 2026 10-Q Quarterly Report
Oct 21, 2026 8-K Current Report
Oct 14, 2026 4 Filing
Oct 09, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 01, 2026 4 Filing
View All SEC Filings ➞
Medpace
Medpace logo
Country United States
IPO Date Aug 11, 2016
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 6,600
CEO August James Troendle

Contact Details

5375 Medpace Way Cincinnati, Ohio 45227 United States

Stock Details

Ticker Symbol MEDP
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001668397
CUSIP Number 58506Q109
ISIN Number US58506Q1094
SIC Code 8731

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.